Adding the antiangiogenic drug to standard care does not extend overall survival among patients with metastatic esophageal ...
MedPage Today on MSN
Chemotherapy-Free Combo Improves Survival in Metastatic Colorectal Cancer
BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...
Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...
Senator Ted Cruz (R-TX) decried the "growing cancer" of right-wing anti-Semitism in remarks delivered at Hagee Ministries' ...
Why are lobular breast cancers found at later stages? What are the biological hallmarks of this disease? Are there ways to ...
A TV presenter with stage 4 breast cancer has said she's had to "battle" for care. Mum-of-three Mari Grug, 41, was diagnosed ...
Communication between epithelial and mesenchymal cells in pancreatic cancer leads to a poor prognosis. The molecular basis ...
The American Cancer Society is going beyond solely identifying the issue of financial toxicity; they’re actively working to ...
Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...
Mail-in stool kits such as Colorguard can detect warning signs, but gastroenterologists say a colonoscopy is still the most ...
Alecensa (alectinib) demonstrated a 22% reduction in the risk of death compared with Xalkori (crizotinib) in the frontline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results